Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide

To report the control of intraocular pressure (IOP) after removal of subtenon triamcinolone acetonide (TA) plaques in patients with uncontrolled ocular hypertension after posterior subtenon injection of triamcinolone acetonide (PSTA) and to evaluate the factors associated with rapid IOP normalizatio...

Full description

Saved in:
Bibliographic Details
Published inJournal of glaucoma Vol. 25; no. 3; p. e268
Main Authors Chan, Li-Wei, Hsu, Wei-Cherng, Hsieh, Yi-Ting
Format Journal Article
LanguageEnglish
Published United States 01.03.2016
Subjects
Online AccessGet more information

Cover

Loading…
Abstract To report the control of intraocular pressure (IOP) after removal of subtenon triamcinolone acetonide (TA) plaques in patients with uncontrolled ocular hypertension after posterior subtenon injection of triamcinolone acetonide (PSTA) and to evaluate the factors associated with rapid IOP normalization after subtenon TA removal. Data from 8 eyes of 7 patients receiving excision of subtenon TA plaques for uncontrolled ocular hypertension after PSTA in 1 hospital from June 2010 to December 2012 were retrospectively collected. The percentage of IOP lowering on postoperative day 1 and the time to IOP normalization after subtenon TA removal were reported. Pearson correlation analysis was used to analyze the factors for rapid IOP normalization after subtenon TA removal. The IOP lowering on postoperative day 1 ranged from 12% to 75%. All cases achieved IOP normalization within a mean of 2.5±1.9 days (range, 1 to 5 d) after subtenon TA removal. Fewer kinds of antiglaucoma agents used before subtenon TA removal was associated with greater IOP lowering on postoperative day 1 (P=0.01) and more rapid return to normal IOP (P=0.01). Older age and more time from PSTA to ocular hypertension were both correlated with shorter time to achieve IOP normalization after operation (P=0.01 and 0.02, respectively). In medically uncontrolled ocular hypertension after PSTA, excision of subtenon TA plaques provided IOP normalization as rapidly as 1 to 5 days. Fewer preoperative antiglaucoma agents, older age, and more time from PSTA to ocular hypertension were correlated with more rapid IOP normalization after subtenon TA removal.
AbstractList To report the control of intraocular pressure (IOP) after removal of subtenon triamcinolone acetonide (TA) plaques in patients with uncontrolled ocular hypertension after posterior subtenon injection of triamcinolone acetonide (PSTA) and to evaluate the factors associated with rapid IOP normalization after subtenon TA removal. Data from 8 eyes of 7 patients receiving excision of subtenon TA plaques for uncontrolled ocular hypertension after PSTA in 1 hospital from June 2010 to December 2012 were retrospectively collected. The percentage of IOP lowering on postoperative day 1 and the time to IOP normalization after subtenon TA removal were reported. Pearson correlation analysis was used to analyze the factors for rapid IOP normalization after subtenon TA removal. The IOP lowering on postoperative day 1 ranged from 12% to 75%. All cases achieved IOP normalization within a mean of 2.5±1.9 days (range, 1 to 5 d) after subtenon TA removal. Fewer kinds of antiglaucoma agents used before subtenon TA removal was associated with greater IOP lowering on postoperative day 1 (P=0.01) and more rapid return to normal IOP (P=0.01). Older age and more time from PSTA to ocular hypertension were both correlated with shorter time to achieve IOP normalization after operation (P=0.01 and 0.02, respectively). In medically uncontrolled ocular hypertension after PSTA, excision of subtenon TA plaques provided IOP normalization as rapidly as 1 to 5 days. Fewer preoperative antiglaucoma agents, older age, and more time from PSTA to ocular hypertension were correlated with more rapid IOP normalization after subtenon TA removal.
Author Hsu, Wei-Cherng
Hsieh, Yi-Ting
Chan, Li-Wei
Author_xml – sequence: 1
  givenname: Li-Wei
  surname: Chan
  fullname: Chan, Li-Wei
  organization: Department of Ophthalmology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei†School of Medicine, Tzu Chi University, Hualien‡Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan
– sequence: 2
  givenname: Wei-Cherng
  surname: Hsu
  fullname: Hsu, Wei-Cherng
– sequence: 3
  givenname: Yi-Ting
  surname: Hsieh
  fullname: Hsieh, Yi-Ting
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26950466$$D View this record in MEDLINE/PubMed
BookMark eNp10N1KwzAUB_AgivvQNxDJC3QmaZO2l2XoVhlMdAPvRpqcQEeblLQV9gy-tBE_8MZz84fDOb8DZ4bOrbOA0A0lC0ry9K58XC3I32K5OENTymMRJRl9naBZ3x9DmzBGL9GEiZyTRIgpen8ZqwECh3e-lq2qrWuCjQsFg7O1BvwMrXuTDTbO471Vzg7eNQ1ovFVjIz1enzrwgejrgBRmAI-fXB-iDgu_emmPoIbPEWf-O3WFLoxserj-zjnaP9zvlutos12Vy2ITqZgLEVVCKCCUcq5Nyo1UKbA0JlWeSKIEIxUwrQzjvMolcE6oSDIdEyMzqZU0gs3R7ZfbjVUL-tD5upX-dPj5CvsAbuppRw
CitedBy_id crossref_primary_10_51847_44gUM9g3fF
crossref_primary_10_1080_02713683_2020_1826979
crossref_primary_10_1007_s40278_016_17792_7
crossref_primary_10_1016_j_survophthal_2020_01_002
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1097/IJG.0000000000000296
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1536-481X
ExternalDocumentID 26950466
Genre Journal Article
GroupedDBID ---
.-D
.Z2
0R~
2V-
53G
5GY
5VS
8L-
AAAAV
AAHPQ
AAIQE
AARTV
AASCR
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABVCZ
ABXRP
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACWDW
ACWRI
ACXJB
ACXNZ
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFDTB
AFUWQ
AGINI
AHQNM
AHRYX
AHVBC
AINUH
AJIOK
AJNWD
AJNYG
AJZMW
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BQLVK
BS7
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
DUNZO
E.X
EBS
ECM
EEVPB
EIF
EJD
EX3
F2K
F2L
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
L-C
N9A
NPM
N~M
O9-
OCUKA
ODA
OJAPA
OL1
OLG
OLV
OLW
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OXXIT
P-K
P2P
R58
RIG
RLZ
S4R
S4S
TEORI
TSPGW
V2I
W3M
WOQ
WOW
X3V
X3W
YFH
ZB8
ZFV
ZZMQN
ID FETCH-LOGICAL-c3566-b66ce01155df75fac7e2730b94a0c620be2dcf255b9ae5501648d30fa8adcaf62
IngestDate Tue Aug 27 13:56:34 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3566-b66ce01155df75fac7e2730b94a0c620be2dcf255b9ae5501648d30fa8adcaf62
PMID 26950466
ParticipantIDs pubmed_primary_26950466
PublicationCentury 2000
PublicationDate 2016-March
PublicationDateYYYYMMDD 2016-03-01
PublicationDate_xml – month: 03
  year: 2016
  text: 2016-March
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of glaucoma
PublicationTitleAlternate J Glaucoma
PublicationYear 2016
SSID ssj0020221
Score 2.1735585
Snippet To report the control of intraocular pressure (IOP) after removal of subtenon triamcinolone acetonide (TA) plaques in patients with uncontrolled ocular...
SourceID pubmed
SourceType Index Database
StartPage e268
SubjectTerms Adult
Aged
Device Removal
Drug Implants
Female
Glucocorticoids - administration & dosage
Glucocorticoids - adverse effects
Humans
Injections, Intraocular
Intraocular Pressure - physiology
Macular Edema - drug therapy
Male
Middle Aged
Ocular Hypertension - chemically induced
Ocular Hypertension - physiopathology
Retrospective Studies
Tenon Capsule - drug effects
Tonometry, Ocular
Triamcinolone Acetonide - administration & dosage
Triamcinolone Acetonide - adverse effects
Title Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide
URI https://www.ncbi.nlm.nih.gov/pubmed/26950466
Volume 25
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswFCScFgh6Cbqle8FDr3RlSiatoxG0dQIkvThoegrEDVEQJ0Eb55BfyAf0dztcJKuuDbj1QTBEmKQ1I3Ie8RZCPgxyV3DNHXOZtAwKnLPSBwJjGSyNMNiEpA8UPjwSk-Pi4GR40uv96ngtzW9UX9-tjCv5H1RxD7j6KNl_QLbtFDfwHfjiCoRx3QhjvPWQvMBvisFmuvZn5BCNY22h6GrjSzLMrm5jiCLUZXJLv4DG_BrdTyewQn8EH3Z0Mg7lwn31XswdP2h73788t7pRlmuGWiNyIc7n-OcLd6CzFOtQs2-2bjn1cx58_WzN9sChtJmGhtqGc5_vNZs2m2w6oxiIhZNW3zbrqmDFKFTHaRfeGPGcCJZ3VlHLY6mdv5b3mDZ4_-BLTDvZfHgsittB_HoWIOeiHGaF2KB1Kel207RFtuTIL59H_hAo2fGQPYMmCrOUH1dNx-eYTl0s2StBt0wfk52EBR1H9jwhPXv5lGwfJpeKZ-S-gZn-gSxtkaWJRBQkol0S0Ugi2iURDSSiLYlo23tLInrl1g31nBx__jTdm7BUoYPpHHYAU0Jo642KoXFy6CotLeRwpsqiyrTgmbLcaAerVZWVhS0M23xk8sxVo8roygm-Sx5gCvYloT6VZaGxv8hSQcJLVUhdVNYYmH-K5_kr8iI-xtPrmIbltHnAr9e2vCGPFmx8Sx46vPf2HUTkjXofIP0NTIl1Pg
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Subtenon+Triamcinolone+Acetonide+Removal+for+Uncontrolled+Ocular+Hypertension+After+Posterior+Subtenon+Injection+of+Triamcinolone+Acetonide&rft.jtitle=Journal+of+glaucoma&rft.au=Chan%2C+Li-Wei&rft.au=Hsu%2C+Wei-Cherng&rft.au=Hsieh%2C+Yi-Ting&rft.date=2016-03-01&rft.eissn=1536-481X&rft.volume=25&rft.issue=3&rft.spage=e268&rft_id=info:doi/10.1097%2FIJG.0000000000000296&rft_id=info%3Apmid%2F26950466&rft_id=info%3Apmid%2F26950466&rft.externalDocID=26950466